PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors who purchased stock in Open Lending Corp. (NASDAQ: LPRO) between February 24, 2022 and March 31, 2025.  Open Lending is a provider of services to automotive lenders. WHAT’S THIS ABOUT?On March 17, 2025, Open Lending announced that it would postpone its earnings release and conference call, both scheduled for the same day. The company also filed a ...

ATLANTA, May 02, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Open Lending Corporation (“Open Lending” or the “Company”) (NASDAQ: LPRO). The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding Open Lending’s business, operations, and prospects, including allegations that Defendants: (1) misrepresented the capabilities of Open Lending’s risk-based pricing models; (2) issued mater ...

SAN DIEGO, May 1, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Fluence Energy, Inc. (NASDAQ: FLNC) Class A common stock between October 28, 2021 and February 10, 2025, inclusive (the "Class Period"), have until May 12, 2025 to seek appointment as lead plaintiff of the Fluence Energy class action lawsuit. Captioned Kramer v. Fluence Energy, Inc., No. 25-cv-00634 (E.D. Va.), the Fluence Energy class action lawsuit charges Fluence Energy as well as certain of Fluence Energ ...

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Napco Security Technologies, Inc. (NASDAQ: NSSC) securities between February 5, 2024 and February 3, 2025. Napco develops, manufactures, and sells high-tech electronic security devices and provides cellular communication services for intrusion and fire alarm systems. For more information, submit a form, email attorney Aaron Dumas, Jr., or ...

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. ICU Medical is the subject of an FDA warning letter published on April 22, 2025. According to the government agency, the Company "made multiple changes to the Medfusion Model 4000 Syringe Infusion Pump and CADD Solis VIP Ambulatory Infusion Pump that could significantly affect the safety or effectiveness of these devices." The FDA states that the Company's ...